Two Senior MEDIROM Mother Labs Executives Invest in Mother Labs' Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000)
- TOKYO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (the “Company” or “MEDIROM”) announces that two senior executives, Issei Homan, Chief Technology Officer of MEDIROM MOTHER Labs Inc. (“Mother Labs”), a subsidiary of MEDIROM, and Yasuhiro Hayami, Chief Business Officer of Mother Labs, invested in Mother Labs' Series A financing at a pre-money valuation of of JPY9 billion (as of December 1, 2024, approximately USD $59,000,000). Messrs. Homan and Hayami are committed senior executives of Mother Labs and share MEDIROM's corporate philosophy and vision as well as commitment to future growth potential.
- 12/11/2024
|
MEDIROM Healthcare Technologies Inc. Announces Pricing of Public Offering
- TOKYO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM), “MEDIROM”, a holistic healthcare company that operates over 300 wellness salons across Japan and provides healthcare services, today announced the pricing of a public offering of 2,860,000 American Depositary Shares at a public offering price of $1.75 per share, for gross proceeds of approximately $5,000,000, before deducting underwriting discounts and offering expenses. In addition, MEDIROM has granted the underwriters a 45-day option to purchase up to an additional 429,000 American Depositary Shares to cover over-allotments at the public offering price, less the underwriting discount. The Offering is expected to close on December 11, 2024, subject to the satisfaction of customary closing conditions.
- 12/09/2024
|
UPDATE: MEDIROM Healthcare Technologies Has Received Orders for Over 25,000 MOTHER Bracelet Units
- TOKYO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) announces that its subsidiary MEDIROM MOTHER Labs Inc. has received orders for over 25,000 MOTHER Bracelet units, including orders from Japanese companies such as NFES Technologies Inc.
- 12/09/2024
|
MEDIROM Healthcare Technologies Has Received Orders for Over 25,000 MOTHER Bracelet Units
- TOKYO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) announces that its subsidiary MEDIROM MOTHER Labs Inc. has received orders for over 25,000 MOTHER Bracelet units, including orders from Japanese companies such as NFES Technologies Inc.
- 12/09/2024
|
M3 Group Joins MEDIROM Mother Labs' Series A Financing Round at JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000) Pre-Money Valuation
- TOKYO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) announces that M3, Inc. (TOKYO PRIME: 2413), or an affiliate within the M3 group, is participating in the Series A equity financing round of MEDIROM MOTHER Labs Inc., a subsidiary of MEDIROM. NFES Technologies Inc. is the lead investor of the Series A financing round at a pre-money valuation of JPY9 billion. Additional information is available here: https://medirom.co.jp/en/ir/20240824/6148%09
- 12/06/2024
|
M3 Group Joins MEDIROM Mother Labs' Series A Financing Round at JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000) Pre-Money Valuation
- TOKYO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) announces that M3, Inc. (TOKYO PRIME: 2413), or an affiliate within the M3 group, is participating in the Series A equity financing round of MEDIROM MOTHER Labs Inc., a subsidiary of MEDIROM. NFES Technologies Inc. is the lead investor of the Series A financing round at a pre-money valuation of JPY9 billion. Additional information is available here: https://medirom.co.jp/en/ir/20240824/6148%09
- 12/02/2024
|
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance
- TOKYO--(BUSINESS WIRE)-- #InvestorRelations--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) , announced a business alliance with MEDIROM Healthcare Technologies Inc.(Nasdaq: MRM) .
- 11/07/2024
|
MEDIROM Rehab Solutions Inc. Acquires Rehabilitation Centers from Y's, Inc.
- TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” or the “Company”) is pleased to announce that it is capitalizing on its extensive experience operating wellness clinics and healthcare technology to expand into the rehabilitation industry. In doing so, MEDIROM established a wholly-owned subsidiary, MEDIROM Rehab Solutions Inc., which acquired all of the rehabilitation centers of Y's, Inc. Prior to the acquisition by MEDIROM Rehab Solutions Inc., Y's, Inc. owned and operated ten cerebral infarction rehabilitation centers in Tokyo and other major cities across Japan.
- 10/07/2024
|
Capital and Business Alliance Formed Between MEDIROM MOTHER Labs and NFES Technologies
- NFES Group Selected as Lead Investor in Series A Round Valued at 9 Billion Yen NFES Group Selected as Lead Investor in Series A Round Valued at 9 Billion Yen
- 08/23/2024
|
MEDIROM Healthcare Technologies Announces Business Transfer from Y's, Inc.
- TOKYO, July 22, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (“we”, “our”, “us” or “the Company”) hereby announces that its subsidiary MEDIROM Rehab Solutions Inc. entered into an agreement to purchase a rehabilitation business from Y's, Inc., a Japanese corporation, as of July 10, 2024.
- 07/22/2024
|
MEDIROM Healthcare Technologies Announces Acquisition of Japan Gene Medicine Corporation
- NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (“we”, “our”, “us” or “the Company”) hereby announces that the Company plans to acquire a majority of Japan Gene Medicine Corporation (the “Target Company”). On June 30, 2024, the Company entered into a share transfer agreement (the "Share Transfer Agreement") to acquire 70.0% of the shares of the Target Company from an individual shareholder. The Company has also entered into a legally binding memorandum of understanding (the "Additional Transfer Memorandum of Understanding"), effective as of June 30, 2024, to obtain an option to acquire the remaining 30.0% of the Target Company's shares from the seller. The closings of the transactions under the Share Transfer Agreement and Additional Transfer Memorandum of Understanding are each subject to certain conditions. Certain of these closing conditions under the Share Transfer Agreement are summarized below.
- 07/10/2024
|
The first JAPAN IR Event 2024 was held at Nasdaq's U.S. headquarters
- Four Nasdaq-listed Japanese Companies Gather to Showcase the Appeal of Japanese Companies to the World Four Nasdaq-listed Japanese Companies Gather to Showcase the Appeal of Japanese Companies to the World
- 07/01/2024
|
MEDIROM Healthcare Technologies Inc. Announces Financial Results for Fiscal Year 2023
- TOKYO, June 25, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” or the “Company”), a holistic healthcare company based in Japan, announced it filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission ("SEC"), including consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), on June 18, 2024.
- 06/25/2024
|
“NASDAQ JAPAN IR EVENT” to Be Held at Nasdaq MarketSite on June 20, 2024
- NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (“MEDIROM”, the “Company”), today announced it will participate in a “NASDAQ JAPAN IR EVENT” to be held at Nasdaq MarketSite in Times Square on June 20, 2024. Five companies are currently expected to join this event (including one private company), and we will share information about the attractive nature of the Japanese market with a global audience.
- 05/20/2024
|
MEDIROM Healthcare Technologies Inc. Announces March 2024 Key Performance Indicators (KPIs)
- TOKYO, April 25, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of March 2024. Data is provided for all salons for which comparative financial and customer data is available and excludes certain salons where such information is not available.
- 04/25/2024
|
Announcement Execution of Memorandum of Understanding for Share Acquisition (Subsidiarization)
- NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (“we”, “our” or “us”) hereby announces that we resolved, at a meeting of our Board of Directors held on March 29, 2024, to enter into a Memorandum of Understanding (the “MOU”) for the purpose of acquiring all of the shares of stock of Japan Gene Medicine Corporation (the “Target Company”) and making it our subsidiary, and commencing the processes and negotiations necessary to enter into the definitive agreement for the transaction. The MOU was executed on April 2, 2024.
- 04/02/2024
|
7 Stocks to Buy in November in Light of Their October Dip
- October was a good month in the markets. It won't be easy to find stocks to buy on the dip.
- 11/15/2021
|
DBGI Stock News: Why Jim Cramer Thinks Digital Brands Is Today's ‘Pump and Dump'
- Digital Brands (DBGI) stock is running higher on Thursday as Jim Cramer calls it out as the new pump and dump of Reddit traders. The post DBGI Stock News: Why Jim Cramer Thinks Digital Brands Is Today's ‘Pump and Dump' appeared first on InvestorPlace.
- 09/23/2021
|
MRM Stock: The Hair Salon Deal That has Holistic Healthcare Play Medirom All Lathered Up Today
- Medirom Healthcare Technologies (MRM) stock is rocketing higher on Thursday following news of a major deal for the company. The post MRM Stock: The Hair Salon Deal That has Holistic Healthcare Play Medirom All Lathered Up Today appeared first on InvestorPlace.
- 09/23/2021
|
MRM Stock: Why It Substantially Increased Today
- The stock price of Medirom Healthcare Technologies Inc (NASDAQ: MRM) is trading at over 80% pre-market today. This is why it happened.
- 09/23/2021
|
MEDIROM Healthcare Technologies Inc. Announces its latest Key Performance Indicators (KPIs)
- NEW YORK, Sept. 22, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a Japanese based holistic healthcare Company (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of August 2021. Data is provided for all salons for which comparative financial and customer data is available and excludes certain salons where such information is not available.
- 09/22/2021
|
MEDIROM Healthcare Technologies Inc., Announces Acquisition of ZACC Kabushiki Kaisha
- NEW YORK, Sept. 22, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a Japanese-based holistic healthcare Company (the “Company” or “MEDIROM”), today announced that it has entered into a share transfer agreement (the “Agreement”) with all of the existing shareholders of ZACC Kabushiki Kaisha (“ZACC”), a Japanese hair salon operator of “ZACC” brand, pursuant to which it will acquire 100% of the shares of ZACC through a two-stage acquisition for total consideration of 370,000,000 Japanese yen (which we refer to as “¥”) ($3,362,108.13). ZACC owns and operates three (3) luxury hair salon brands, ZACC vie, ZACC raffine, and Zacc ginza, all of which has been recognized by customers for over 30 years for their high level of techniques and hospitality.
- 09/22/2021
|
MEDIROM Healthcare Technologies Inc., Announces its latest Key Performance Indicators (KPIs)
- NEW YORK, Aug. 19, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a Japanese based holistic healthcare Company (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of July 2021. Data is provided for all salons for which comparative financial and customer data is available and excludes certain salons where such information is not available.
- 08/19/2021
|
MEDIROM Healthcare Technologies Inc., Announces the Timing of its Release of 2021 Interim Earnings
- NEW YORK, Aug. 19, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a Japanese based holistic healthcare Company (the “Company”), today announced its intention to release interim financial results for the six months ended June 30, 2021 (the “2021 Interim Results”) at or around the end of October 2021.
- 08/19/2021
|
MEDIROM Healthcare Technologies Inc., Announces its latest Key Performance Indicators (KPIs)
- NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a Japanese based holistic healthcare Company (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of June 2021. Data is provided for all salons for which comparative financial and customer data is available and excludes certain salons where such information is not available.
- 07/19/2021
|
MEDIROM Healthcare Technologies Inc., Announces its latest Key Performance Indicators (KPIs)
- NEW YORK, June 22, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM:MRM), a Japanese based holistic healthcare Company (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of May 2021. Data is provided for all salons for which comparative financial and customer data is available and excludes certain salons where such information is not available.
- 06/22/2021
|
MEDIROM Partners with Sanei Electronics for Manufacture of MOTHER Tracker®, with Canon Electronics as the Manufacturing Subcontractor
- NEW YORK, May 21, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), headquartered in Tokyo, Japan ("MEDIROM"), today announced that the Company has entered into a Master Manufacturing Agreement with Sanei Electronics Co., Ltd., Tokyo, Japan ("Sanei"), with respect to the production of the Company's MOTHER Tracker®, an activity tracker (hereinafter referred as "MOTHER Tracker®"), and has commenced preparations for production and shipment. Sanei is subcontracting with Canon Electronics Co., Ltd., Chichibu, Japan (“Canon Electronics”) for part of the production.
- 05/21/2021
|
MEDIROM Healthcare Technologies Inc., Announces its latest Key Performance Indicators (KPIs)
- NEW YORK, May 17, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM:MRM), a Japanese based holistic healthcare Company (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of April 2021.
- 05/17/2021
|
MEDIROM Healthcare Technologies Inc. to Report Financial Results for the Year Ending 2020 on Monday, May 17, 2021
- Conference Call to be held Monday May 17, 2021 at 4:30 p.m. ET Conference Call to be held Monday May 17, 2021 at 4:30 p.m. ET
- 05/17/2021
|
MEDIROM Healthcare Technologies Inc. Announces The Acquisition of Relaxation Salon Business under the Brand Name of “Ruam Ruam”
- NEW YORK, April 30, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM, “MEDIROM”), a leading holistic health services provider in Japan, announced today that MEDIROM has acquired 100% ownership of SAWAN CO. LTD. (“SAWAN”), a relaxation salon operator of “Ruam Ruam” from BOX GROUP Co., Ltd., a Japanese holding company specializing in beauty and spa products and services. Ruam Ruam is a luxury relaxation salon brand, which is characterized with Oriental relaxation techniques to fit the needs and preferences of the Japanese consumer. SAWAN directly operates eight (8) salons across the Tokyo metropolitan area.
- 04/30/2021
|
MEDIROM Healthcare Technologies Inc., Announces its latest Key Performance Indicators (KPIs)
- NEW YORK, April 15, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a Japanese based holistic healthcare Company (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of March 2021.
- 04/15/2021
|
MEDIROM Healthcare Technologies Inc. Enters into Strategic Partnership with ZACC Kabushiki-Kaisha (Corporation), a Japan- based Owner/Operator of Hair Salons
- TOKYO, April 15, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM) (the "Company"), today announced that it has signed a "Letter of Intent" with ZACC Kabushiki-Kaisha (“ZACC”), an owner and operator of hair salons in Tokyo, Japan to launch jointly operated hair and beauty salons incorporating the Company's franchising expertise and unique human resource management programs to accelerate and enhance new ZACC brand store openings in Japan and overseas.
- 04/15/2021
|
MEDIROM Healthcare Technologies Inc. Announces Exercise and Closing of Over-Allotment Option in Initial Public Offering
- NEW YORK, Feb. 01, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM:MRM), a holistic healthcare company from Japan (the “Company”), announced today that it has completed the sale of an additional 60,000 ADSs (each ADS representing one common share, no par value) at the public offering price of US$15.00 per ADS, pursuant to the exercise by the underwriter of the over-allotment option granted to it in connection with the Company's initial public offering. The Company expects to receive additional net proceeds of approximately US$837,000, after underwriting discounts and commissions.
- 02/01/2021
|
U.S. IPO Week Ahead: Diverse 8 IPO Week Features 3 Billion-Dollar Deals
- The US IPO market is expected to remain active in the week ahead with eight IPOs slated to raise $4.6 billion. Street research is expected for Medirom Healthcare Technologies on Monday, 1/25.
- 01/24/2021
|
MEDIROM Healthcare Technologies Inc. Announces Closing of $12,000,000 Initial Public Offering
- NEW YORK, Dec. 31, 2020 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM:MRM), a holistic healthcare company from Japan (the “Company”), announced today that it has closed its previously announced initial public offering of 800,000 ADSs at a price to the public of US$15.00 per share. Each ADS represents one share of the Company's common stock. After underwriting discounts and offering expenses, the Company expects to receive net proceeds of approximately US$7.8 million.
- 12/31/2020
|
MEDIROM Healthcare Technologies Inc. Announces Pricing of Upsized $12.0 Million Initial Public Offering and Listing on NASDAQ
- NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM:MRM) (“MEDIROM”), the holistic healthcare company from Japan, announced the pricing of its initial public offering of 800,000 American Depositary Shares (ADSs) at a price of US$15.00 per ADS. Each ADS represents one common share of MEDIROM. The ADSs are expected to begin trading on the Nasdaq Capital Market on December 29, 2020, under the symbol “MRM.” Gross proceeds before deducting underwriting discounts and commissions and other offering expenses are expected to be US$12.0 million. The closing of the offering is expected to occur on December 31, 2020, subject to the satisfaction of customary closing conditions.
- 12/28/2020
|
Medirom Healthcare Technologies Seeks $18 Million U.S. IPO
- Medirom Healthcare Technologies has filed to raise $18 million in a small U.S. IPO. The firm operates and franchises wellness salons in Japan.
- 12/08/2020
|
